Treadwell Announces Initiation New Clinical Trial CFI 400945

Oct 19, 2020

Treadwell Announces Initiation of New Clinical Trial of CFI-400945 in Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC)